SpeeDx Overview
- Year Founded
-
2009

- Status
-
Private
- Employees
-
84

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$22.2M
- Investors
-
14
SpeeDx General Information
Description
Developer of a molecular diagnostics test portfolio designed to provide innovative multiplex systems for clinical diagnostics. The company's test portfolio uses real-time polymerase chain reaction technology for multiplex detection and priming strategies, enabling physicians to test infectious disease and antibiotic resistance.
Contact Information
Website
www.plexpcr.comCorporate Office
- National Innovation Centre, 4 Cornwallis Street
- Suite 102
- Eveleigh, New South Wales 2015
- Australia
Corporate Office
- National Innovation Centre, 4 Cornwallis Street
- Suite 102
- Eveleigh, New South Wales 2015
- Australia
SpeeDx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
13. Later Stage VC | 28-Feb-2023 | $22.2M | Completed | Generating Revenue | ||
12. Secondary Transaction - Private | Completed | Generating Revenue | ||||
11. Grant | 10-May-2021 | Completed | Generating Revenue | |||
10. Later Stage VC (Series B) | 11-Feb-2020 | Completed | Generating Revenue | |||
9. Later Stage VC | 05-Aug-2019 | Completed | Generating Revenue | |||
8. Later Stage VC (Series A) | 23-Apr-2019 | Completed | Generating Revenue | |||
7. Later Stage VC | 01-Jan-2018 | Completed | Generating Revenue | |||
6. Grant | 04-Sep-2017 | Completed | Generating Revenue | |||
5. Grant | 01-Aug-2016 | $753K | Completed | Generating Revenue | ||
4. Grant | 01-Jul-2016 | Completed | Generating Revenue |
SpeeDx Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
PREFERRED SERIES B | ||||||||
PREFERRED SERIES A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
SpeeDx Comparisons
Industry
Financing
Details
SpeeDx Competitors (7)
One of SpeeDx’s 7 competitors is Meridian Bioscience, a Private Equity-Backed company based in Cincinnati, OH.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Meridian Bioscience | Private Equity-Backed | Cincinnati, OH | ||||
Illumina | Formerly VC-backed | San Diego, CA | ||||
AusDiagnostics | Private Equity-Backed | Mascot, Australia | ||||
Cepheid | Formerly VC-backed | Sunnyvale, CA | ||||
Diagnostic Technology | Corporation | Belrose, Australia |
SpeeDx Patents
SpeeDx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2024903744-A0 | Temperature dependent probes for target detection | Pending | 14-Nov-2024 | ||
AU-2023901468-A0 | Target detection using temperature controlled probes | Pending | 15-May-2023 | ||
AU-2024220029-A1 | Target detection using temperature controlled probes | Pending | 15-May-2023 | ||
EP-4172355-A1 | Multiplex detection of nucleic acids using mixed reporters | Pending | 30-Jun-2020 | ||
AU-2020256848-A1 | Multiplex detection of nucleic acids using mixed reporters | Pending | 30-Jun-2020 | C12Q1/6818 |
SpeeDx Signals
SpeeDx Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
10K Lakes Capital | PE/Buyout | Minority | ||
Tenmile | Venture Capital | Minority | ||
West Midlands Pension Fund | Limited Partner | Minority | ||
CARB-X | University | |||
Illumina Ventures | Venture Capital | Minority |
SpeeDx FAQs
-
When was SpeeDx founded?
SpeeDx was founded in 2009.
-
Where is SpeeDx headquartered?
SpeeDx is headquartered in Eveleigh, Australia.
-
What is the size of SpeeDx?
SpeeDx has 84 total employees.
-
What industry is SpeeDx in?
SpeeDx’s primary industry is Diagnostic Equipment.
-
Is SpeeDx a private or public company?
SpeeDx is a Private company.
-
What is SpeeDx’s current revenue?
The current revenue for SpeeDx is
. -
How much funding has SpeeDx raised over time?
SpeeDx has raised $62.3M.
-
Who are SpeeDx’s investors?
10K Lakes Capital, Tenmile, West Midlands Pension Fund, CARB-X, and Illumina Ventures are 5 of 14 investors who have invested in SpeeDx.
-
Who are SpeeDx’s competitors?
Meridian Bioscience, Illumina, AusDiagnostics, Cepheid, and Diagnostic Technology are some of the 7 competitors of SpeeDx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »